Vertex Pharma (VRTX) Appoints IBM's (IBM) Yuchun Lee to Board
Tweet
Share
E-mailGet Alerts VRTX Hot Sheet
Join SI Premium – FREE
Vertex Pharmaceuticals, Inc. (Nasdaq: VRTX) nnounced that Yuchun Lee joined its board of directors as an independent director. Mr. Lee was appointed to the class of directors whose term expires in 2013. The Vertex board currently consists of 10 members.
Lee is currently the Vice President and General Manager of IBM’s (NYSE: IBM) Enterprise Marketing Management Group where he directs a team of nearly 2,000 IBM employees and is a key architect in IBM’s global initiative to serve the needs of Chief Marketing Officers. Lee’s team is focused on providing solutions to help businesses better understand their customers via social media, mobile behavior and real-time access to consumer information, leveraging analytics to optimize customer communication and engagement.
Lee is currently the Vice President and General Manager of IBM’s (NYSE: IBM) Enterprise Marketing Management Group where he directs a team of nearly 2,000 IBM employees and is a key architect in IBM’s global initiative to serve the needs of Chief Marketing Officers. Lee’s team is focused on providing solutions to help businesses better understand their customers via social media, mobile behavior and real-time access to consumer information, leveraging analytics to optimize customer communication and engagement.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Vortex Energy Engages Market Maker
- Genworth Financial CEO returns from leave of absence in September
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
